Ascertainment Bias in Statin Use and Alzheimer Disease Incidence
JAMA Neurol
.
2017 Jul 1;74(7):868.
doi: 10.1001/jamaneurol.2017.0427.
Authors
D Michal Freedman
1
,
Ruth M Pfeiffer
1
Affiliation
1
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.
PMID:
28459949
DOI:
10.1001/jamaneurol.2017.0427
No abstract available
Publication types
Comment
MeSH terms
Alzheimer Disease*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Incidence
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors